| Primary |
| Product Used For Unknown Indication |
34.0% |
| Drug Use For Unknown Indication |
19.8% |
| Intravenous Catheter Management |
6.6% |
| Infection |
3.8% |
| Medication Dilution |
3.8% |
| Asthma |
2.8% |
| Body Temperature Decreased |
2.8% |
| Indwelling Catheter Management |
2.8% |
| Pain |
2.8% |
| Antibiotic Therapy |
1.9% |
| Cardiac Arrest |
1.9% |
| Cardiac Disorder |
1.9% |
| Cardiac Failure |
1.9% |
| Cystic Fibrosis |
1.9% |
| Epilepsy |
1.9% |
| Haemodialysis |
1.9% |
| Haemodynamic Instability |
1.9% |
| Hypersensitivity |
1.9% |
| Hyponatraemia |
1.9% |
| Neoplasm Malignant |
1.9% |
|
| Poor Quality Drug Administered |
8.0% |
| Rash Erythematous |
8.0% |
| Throat Tightness |
8.0% |
| Transmission Of An Infectious Agent Via A Medicinal Product |
8.0% |
| Vomiting |
8.0% |
| Hepatitis C |
6.0% |
| Medication Error |
6.0% |
| Pharmaceutical Product Complaint |
6.0% |
| Ascites |
4.0% |
| Blood Pressure Increased |
4.0% |
| Death |
4.0% |
| Myocardial Infarction |
4.0% |
| Pallor |
4.0% |
| Staphylococcal Infection |
4.0% |
| Throat Irritation |
4.0% |
| Unresponsive To Stimuli |
4.0% |
| Wrong Drug Administered |
4.0% |
| Abasia |
2.0% |
| Air Embolism |
2.0% |
| Bradycardia |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
24.0% |
| Product Used For Unknown Indication |
12.6% |
| Pneumonia |
8.5% |
| Prophylaxis |
6.1% |
| Prophylaxis Of Nausea And Vomiting |
5.6% |
| Infection Prophylaxis |
5.4% |
| Anaesthesia |
3.8% |
| Pain |
3.6% |
| Ovarian Cancer |
3.4% |
| Plasmapheresis |
3.1% |
| Neuroendocrine Carcinoma |
2.9% |
| Pneumocystis Jiroveci Pneumonia |
2.9% |
| Parenteral Nutrition |
2.7% |
| Thrombosis Prophylaxis |
2.5% |
| Caesarean Section |
2.2% |
| Fungal Infection |
2.2% |
| Gastrointestinal Disorder |
2.2% |
| Hypertension |
2.2% |
| Diarrhoea |
2.0% |
| Fluid Replacement |
2.0% |
|
| Poor Quality Drug Administered |
24.1% |
| Toxic Epidermal Necrolysis |
11.5% |
| Disseminated Intravascular Coagulation |
9.2% |
| Pharmaceutical Product Complaint |
8.0% |
| Myocardial Infarction |
6.9% |
| Thrombocytopenia |
4.6% |
| Anaphylactic Reaction |
3.4% |
| Medication Error |
3.4% |
| Vomiting |
3.4% |
| Anaphylactic Shock |
2.3% |
| Ascites |
2.3% |
| Dyspnoea |
2.3% |
| Fanconi Syndrome |
2.3% |
| Haematotoxicity |
2.3% |
| Hypertension |
2.3% |
| Injection Site Pruritus |
2.3% |
| Leukopenia |
2.3% |
| Pruritus |
2.3% |
| Purpura |
2.3% |
| Rash Erythematous |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.2% |
| Hypertension |
9.5% |
| Prophylaxis Of Nausea And Vomiting |
8.1% |
| Abdominal Pain |
7.6% |
| Product Used For Unknown Indication |
7.5% |
| Non-small Cell Lung Cancer |
5.5% |
| Prophylaxis |
4.2% |
| Thrombosis Prophylaxis |
3.3% |
| Hiv Infection |
3.3% |
| Pain |
2.9% |
| Diarrhoea |
2.9% |
| Multiple Myeloma |
2.8% |
| Goitre |
2.6% |
| Chest Pain |
2.4% |
| Acute Myeloid Leukaemia |
2.3% |
| Nausea |
1.9% |
| Constipation |
1.8% |
| Hypokalaemia |
1.8% |
| Pneumonia |
1.8% |
| Musculoskeletal Pain |
1.5% |
|
| Vomiting |
17.9% |
| Wound Infection |
13.1% |
| Pyrexia |
7.9% |
| Thrombocytopenia |
6.6% |
| Weight Decreased |
6.1% |
| Pneumonia |
5.2% |
| Renal Infarct |
4.4% |
| Sepsis |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Urinary Tract Infection |
3.9% |
| Unresponsive To Stimuli |
3.1% |
| White Blood Cell Count Increased |
3.1% |
| Diarrhoea |
2.6% |
| Renal Failure |
2.6% |
| Renal Failure Acute |
2.6% |
| Viral Haemorrhagic Cystitis |
2.6% |
| Weight Increased |
2.6% |
| Wheezing |
2.6% |
| Hypersensitivity |
2.2% |
| Hyponatraemia |
2.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
|
